PEP and Carlyle team up in $930m Aus pharma deal

The pair intend to develop new products for iNova, expand its geographical footprint and also acquire new brands.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this